July 11, 2017 TOULOUSE, France–(BUSINESS WIRE)–Regulatory News: VEXIM (Paris:ALVXM) (FR0011072602 – ALVXM), a medical device company specializing in the minimally invasive treatment of vertebral fractures, today announces its consolidated sales results for the second quarter, as of June 30th, 2017. “VEXIM sales performance in the second quarter is in line […]